Objective 3: Training and Communication

Part 3 of the REVIDA Chair focuses on the supervision and support of postgraduate students involved in research programs, by participating in local training programs and promoting exchanges between international and French universities to attract qualified students.

Training

Two PhD students (CIFRE), one M2 work-study student, and three M2 internship students have been recruited. The REVIDA team participated in the development of the Master’s in Infectious Disease Applied Research work-study program at Lyon 1, for which a supervised project was completed in the first semester of 2025 and will be renewed annually. Regarding student reception, a student from the University of Sao Paulo was welcomed to acquire expertise in analyzing the interferon response. Students from the Republic of Congo will also be invited to discuss the Chair’s work within the joint research laboratory.

Communication

To date, 8 scientific articles have been published within the framework of the chair, and the team has participated in 8 national or international conferences in the form of oral or poster communications. 

A motion design video was used to present the concept of universal diagnosis of respiratory viral infections through host response analysis in a simple, visual, and accessible way for all audiences.

Partnership

As part of its partnership with EID@Lyon, the REVIDA Chair participates in the University Diploma program “Acting and Innovating Against Emerging Infectious Diseases.” The objective of this partnership is to support students in implementing strategies to address viral epidemics during migration. The type 1 interferon response as a diagnostic solution, particularly for patients at high risk of infection, is one proposed approach. Students must therefore develop a project to anticipate and control the introduction of emerging viruses, notably with an innovative test based on the host’s immune response. They will have to design screening devices and protocols adapted to passengers arriving from identified areas, considering the level of knowledge about the virus, airport constraints (premises, staff, etc.), passenger comfort, and the regulatory framework.